Alzheimer’s disease affects an estimated 400,000 people in the UK – that number will double over coming decades without treatments to delay or prevent disease. We are now able to ‘see’ the earliest brain changes of Alzheimer’s disease, which can appear years before first symptoms, opening up the possibility of presymptomatic trials. With serial imaging and videos of patients and at-risk individuals this lecture considers the potential and problems for such trials.